EAM
EFG Asset Management Portfolio holdings
AUM
$708M
This Quarter Return
-8.89%
1 Year Return
+34.17%
3 Year Return
+178.74%
5 Year Return
–
10 Year Return
–
AUM
$602M
AUM Growth
+$602M
(-18%)
Cap. Flow
-$56.6M
Cap. Flow
% of AUM
-9.41%
Top 10 Holdings %
Top 10 Hldgs %
19.62%
Holding
196
New
22
Increased
46
Reduced
108
Closed
20
Top Buys
| 1 |
Eli Lilly
LLY
|
$6.93M |
| 2 |
Protagonist Therapeutics
PTGX
|
$3.44M |
| 3 |
Semtech
SMTC
|
$2.82M |
| 4 |
Birkenstock
BIRK
|
$2.54M |
| 5 |
Marvell Technology
MRVL
|
$2.5M |
Top Sells
| 1 |
Apple
AAPL
|
$7.11M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.2M |
| 3 |
Shift4
FOUR
|
$3.98M |
| 4 |
Roivant Sciences
ROIV
|
$3.82M |
| 5 |
Alkermes
ALKS
|
$3.73M |
Sector Composition
| 1 | Technology | 28.07% |
| 2 | Healthcare | 26.2% |
| 3 | Industrials | 12.62% |
| 4 | Consumer Discretionary | 12.17% |
| 5 | Financials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$4.24T
| $16.1M | 2.67% | 147,627 -28,697 | -16% | -$3.12M |
|
2
Amazon
AMZN
$2.44T
| $16M | 2.66% | 84,126 -9,536 | -10% | -$1.81M |
|
3
Alphabet (Google) Class A
GOOGL
$2.57T
| $14.9M | 2.47% | 96,319 -3,474 | -3% | -$537K |
|
4
Meta Platforms (Facebook)
META
$1.86T
| $13.6M | 2.25% | 23,533 -906 | -4% | -$522K |
|
|
5
Apple
AAPL
$3.45T
| $12.6M | 2.1% | 56,780 -31,994 | -36% | -$7.11M |
|
6
Palantir
PLTR
$372B
| $11.6M | 1.92% | 137,237 -35,445 | -21% | -$2.99M |
|
|
7
Eli Lilly
LLY
$657B
| $9.71M | 1.61% | 11,761 +8,397 | +250% | +$6.93M |
|
8
Broadcom
AVGO
$1.4T
| $8.32M | 1.38% | 49,672 -3,761 | -7% | -$630K |
|
9
Netflix
NFLX
$513B
| $8M | 1.33% | 8,578 -480 | -5% | -$448K |
|
10
Intuitive Surgical
ISRG
$170B
| $7.31M | 1.21% | 14,759 -3,895 | -21% | -$1.93M |
|
11
Insmed
INSM
$28.8B
| $7.18M | 1.19% | 94,225 -13,400 | -12% | -$1.02M |
|
12
Veeva Systems
VEEV
$44B
| $6.68M | 1.11% | 28,842 -5,734 | -17% | -$1.33M |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.67M | 1.11% | 24,691 -1,955 | -7% | -$528K |
|
14
Halozyme
HALO
$8.56B
| $6.57M | 1.09% | 103,092 -25,202 | -20% | -$1.61M |
|
15
Visa
V
$683B
| $6.57M | 1.09% | 18,760 -4,603 | -20% | -$1.61M |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $6.5M | 1.08% | 73,388 -912 | -1% | -$80.7K |
|
17
argenx
ARGX
$43.6B
| $6.37M | 1.06% | 10,755 -3,769 | -26% | -$2.23M |
|
18
Veracyte
VCYT
$2.39B
| $5.92M | 0.98% | 199,653 -6,574 | -3% | -$195K |
|
19
Costco
COST
$418B
| $5.8M | 0.96% | 6,133 -966 | -14% | -$914K |
|
20
Axon Enterprise
AXON
$58.7B
| $5.67M | 0.94% | 10,783 +2,206 | +26% | +$1.16M |
|
21
Home Depot
HD
$405B
| $5.34M | 0.89% | 14,577 +1,134 | +8% | +$416K |
|
22
Commault Systems
CVLT
$8.3B
| $5.26M | 0.87% | 33,294 -128 | -0.4% | -$20.2K |
|
23
Glaukos
GKOS
$5.5B
| $5.22M | 0.87% | 53,076 -7,516 | -12% | -$740K |
|
24
Vertiv
VRT
$48.7B
| $5.17M | 0.86% | 71,562 +23,365 | +48% | +$1.69M |
|
25
Idexx Laboratories
IDXX
$51.8B
| $5.1M | 0.85% | 12,153 -1,222 | -9% | -$513K |
|